Timdarpacept
Timdarpacept (DNL310) is a recombinant SIRPa-Fc fusion protein that can activate macrophages to enhance anti-tumor activity by blocking CD47-SIRPa[1].
Product Specifications
CAS Number
2749520-17-8
UNSPSC
12352203
Target
CD47
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/timdarpacept.html
Purity
99.95
References & Citations
[1]Timdarpacept
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2842439 100 µL
Phospho-CDK6 (Tyr24) Rabbit pAb, PE-Cy5 conjugated
Sign In for Pricing
View Details 
orb1360549 20 µg
Retinoic Acid Receptor alpha (RARA) Human Over-expression Lysate
Sign In for Pricing
View Details 30697141 1x 10^6 Cells / 1.0 mL
MS4A1 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 126019-PE 100 µL
DR6 (Death Receptor 6, BM018, MGC31965, TNFR Related Death Receptor 6, Tumor Necrosis Factor Receptor Superfamily Member 21, Tumor Necrosis Factor Receptor Superfamily Member 21 Precursor, TNFRSF21) (PE)
Sign In for Pricing
View Details